Study Evaluating Pantoprazole in Adolescents With GERD

Phase 3 Completed 20 enrolled Wyeth is now a wholly owned subsidiary of Pfizer

RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is characterize the PK profile of single and multiple doses of pantoprazole in adolescents aged 12 to 16 years with Gastroesophageal Reflux Disease (GERD).

Timeline

Start: 2007-01
Primary completion: —
Completion: 2007-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pantoprazole	Other / unclassified	—	—

Study Evaluating Pantoprazole in Adolescents With GERD

Summary

Timeline

Drugs

Indications